EP3630291
BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
25.5.2018EP published:
10.1.2024EP application number:
18730042.1
EPO information:
European Patent Register
Max expiry date:
24.5.2038
Title in English:
BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6Language of the patent:
English
Timeline
Today
25.5.2018EP application
10.1.2024EP Publication
Owner
Name:
Cancer Research Technology LimitedAddress:
2 Redman Place, London E20 1JQ, GB
Name:
The Institute of Cancer Research: Royal Cancer HospitalAddress:
123 Old Brompton Road, London SW7 3RP, GB
Inventor
Name:
BELLENIE, Benjamin RichardAddress:
London, SM2 5NG, GB
Name:
CARTER, Michael KeithAddress:
London, SM2 5NG, GB
Name:
CHEUNG, Kwai Ming JackAddress:
London, SM2 5NG, GB
Name:
DAVIS, Owen AlexanderAddress:
London, SM2 5NG, GB
Name:
HOELDER, SwenAddress:
London SM2 5NG, GB
Name:
LLOYD, Matthew GarthAddress:
London, SM2 5NG, GB
Name:
VARELA RODRÍGUEZ, AnaAddress:
London, SM2 5NG, GB
Name:
WOODWARD, HannahAddress:
London, SM2 5NG, GB
Name:
INNOCENTI, PaoloAddress:
London, SM2 5NG, GB
Priority
Number:
201708502Date:
26.5.2017Country:
GB
Number:
201806130Date:
13.4.2018Country:
GB
Classification
Categories:
A61P 35/00, C07D 401/12, C07D 403/12, C07D 413/14, C07D 403/14, C07D 409/14, C07D 417/14, A61K 31/4184